The European Union has reserved 200 million doses of a potential vaccine against Covid-19, the European Commission and the American pharmaceutical group Johnson & Johnson announced Thursday.
The European Union has completed its preliminary discussions with Johnson & Johnson on the advance purchase of 200 million doses of a potential vaccine against Covid-19, the European Commission and the American pharmaceutical group announced Thursday.
Sign a contract if the vaccine is safe and effective
Negotiations will now begin on the signing of a contract providing for the purchase of this vaccine if it proves to be safe and effective, said the European executive, who could also take an option for the purchase of 200 million additional doses.
Johnson & Johnson would be able to produce up to a billion doses of a vaccine by the end of 2021, group executive Johan Van Hoof, director of vaccines at Janssen, a Belgian subsidiary of J&J, told Reuters on Tuesday. .
–
